98%
921
2 minutes
20
Purpose: This study investigated the characteristics of a new shielded diode detector, microSilicon X (model 60022: MSX), for small-field and large-field dosimetry.
Methods: The percent depth dose (PDD), beam profiles, detector output factor (OF ), temperature dependence, dose rate dependence, dose-per-pulse (DPP) dependence, and dose-response linearity of MSX were evaluated in Cyberknife and TrueBeam photon beams and compared with various detectors including microDiamond (PTW model 60019: MD), Sun Nuclear EDGE detector, Photon diode (PTW model 60016: PD), and semiflex ionization chamber (PTW model 31010: IC).
Results: For field sizes ranging from 50 × 50 mm to 400 × 400 mm , MSX-measured OF values were within 1% of the IC-measured values. For the CyberKnife small fields, the maximum difference between the MSX-measured OF and the MD-measured field output factor (Ω) was 4.0%, while the maximum differences were 8.8% and 10.9% for PD and EDGE, respectively. MSX showed a stable response within 0.7% for water temperatures of 5°C to 34°C, while PD and EDGE showed a linear correlation between the water temperature and the response. MSX showed small variations within 0.2% for the dose rate, and PD and EDGE showed logarithmic increases in the response with the dose rate. MSX and MD had smaller DPP dependences than PD and EDGE.
Conclusions: The characteristics of MSX for measurements of small- and large-field photon beams are favorable. Compared to PD, MSX exhibited significant improvement in the over-response for small fields. The OF values measured by MSX were approximately in-between those measured by MD and PD. MSX showed stable responses against water temperature, dose rate, and DPP variations and provided suitable data for a wide range of field sizes. However, careful attention is required for measurements of OF for field sizes of <10 × 10 mm and PDD for field sizes of ≥200 × 200 mm .
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mp.14639 | DOI Listing |
Rheumatol Int
September 2025
Department of Physical Medicine and Rehabilitaton, Ankara Bilkent City Hospital, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Türkiye, Turkey.
The Impact of Obesity and Overweight on Rheumatoid Arthritis Patients: Real-World Insights from a Biologic and Targeted Synthetic DMARDs Registry. The management of rheumatoid arthritis (RA) has advanced with biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs). However, obesity, a common comorbidity, impacts treatment and disease progression efficacy.
View Article and Find Full Text PDFAsia Pac J Clin Oncol
September 2025
Roche Products India Pvt. Ltd, Mumbai, India.
Introduction: Trastuzumab emtansine (T-DM1), an antibody-drug conjugate, targets tumor cells overexpressing human epidermal growth factor receptor 2 (HER2). This single-arm, phase IV study assessed the safety and efficacy of T-DM1 in Indian patients with HER2-positive, locally advanced, or metastatic breast cancer previously treated with trastuzumab and a taxane.
Methods: Patients received T-DM1 (3.
Paediatr Anaesth
September 2025
Department of Otorhinolaryngology, Section of Pediatric Otorhinolaryngology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA.
Introduction: Tonsillectomy is associated with a high rate of postoperative nausea and vomiting (PONV), ranging between 40% and 73%, and dexamethasone has been found to have a prophylactic effect on PONV in children undergoing tonsillectomy. In 2020, there was a sudden, severe shortage of intravenous dexamethasone given its role in treating patients with COVID-19. The primary aim of this study was to investigate the viability of an alternative: non-inferiority of oral versus intravenous dexamethasone for preventing PONV.
View Article and Find Full Text PDFJ Int Med Res
September 2025
Department of Anesthesiology, Lishui People's Hospital, China.
ObjectiveThe sedation protocol for flexible fiberoptic bronchoscopy has long been a matter of inconclusiveness. The aim of this study was to evaluate the safety and efficacy of remimazolam combined with alfentanil in flexible fiberoptic bronchoscopy and provide insights for optimizing clinical anesthesia strategies.MethodsThis study was a randomized, single-blind controlled trial.
View Article and Find Full Text PDFDrug Dev Res
September 2025
Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
The epidermal growth factor receptor (EGFR) is a common diver gene for lung cancer (NSCLC), which leads to an increasing death rate worldwide. This study reports the design, synthesis, and biological evaluation of triazole-clubbed pyrimidine derivatives (RDa-RDm) as potential anticancer agents. Thirteen compounds were synthesized and screened against the A549 lung cancer cell line.
View Article and Find Full Text PDF